Company: GVH
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001213900-25-052766
Chunk: 96

Company: Globavend Holdings Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 96
---
 time a registration statement registering the issuance of the Ordinary Shares underlying
the warrants under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available
funds for the number of Ordinary Shares purchased upon such exercise. If a registration statement registering the issuance of the Ordinary
Shares underlying the Series B Warrants under the Securities Act is not effective or available the holder may, in its sole discretion,
elect to exercise the Series B Warrant through a cashless exercise, in which case the holder would receive upon such exercise the
net number of Ordinary Shares determined according to the formula set forth in the Series B Warrant. No fractional shares will be
issued in connection with the exercise of a Series B Warrant. In lieu of fractional shares, we will pay the holder an amount in cash
equal to the fractional amount multiplied by the exercise price or round up to the next whole share.

Exercise Limitation.A
holder will not have the right to exercise any portion of the Series B Warrant if the holder (together with its affiliates) would
beneficially own in excess of 4.99% of the number of Ordinary Shares outstanding immediately after giving effect to the exercise, as such
percentage ownership is determined in accordance with the terms of the Series B Warrants. However, any holder may increase such percentage
to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days
following notice from the holder to us.

Exercise Price.The
exercise price per whole Ordinary Share purchasable upon exercise of the Series B Warrants is equal to 170% of the price per Ordinary
Unit sold in this Offering.

Zero Exercise Price.A holder of Series B Warrants may, at any time and in its sole discretion, exercise its
Series B Warrants in whole or in part by means of a “zero exercise price” option in which the holder is entitled to
receive a number of Ordinary Shares equal to the product of (a) the number of shares that would be issuable upon exercise of
the Series B Warrant in accordance with the terms of such warrant if such exercise were by means of a
cash exercise rather than a cashless exercise and (b) the quotient obtained by dividing (i) the exercise price minus the
Low Price by (ii) 50% of the Low Price. This “zero exercise price” option is only available at a time when the Low
Price is lower than the